Cited by 50TGF-β signaling in diseasesTelomeres, Telomerase, and SenescenceCancer Cells and Metastasis

Cell-extrinsic consequences of epithelial stress: activation of protumorigenic tissue phenotypes

Open access
Fordyce, Colleen A, Patten, Kelley T, Fessenden, Tim B, DeFilippis, RosaAnna, Hwang, E Shelley, Zhao, Jianxin, Tlsty, Thea D·2012·Breast Cancer Research

Abstract

Introduction: Tumors are characterized by alterations in the epithelial and stromal compartments, which both contribute to tumor promotion. However, where, when, and how the tumor stroma develops is still poorly understood. We previously demonstrated that DNA damage or telomere malfunction induces an activin A-dependent epithelial stress response that activates cell-intrinsic and cell-extrinsic consequences in mortal, nontumorigenic human mammary epithelial cells (HMECs and vHMECs). Here we show that this epithelial stress response also induces protumorigenic phenotypes in neighboring primary fibroblasts, recapitulating many of the characteristics associated with formation of the tumor stroma (for example, desmoplasia). Methods: The contribution of extrinsic and intrinsic DNA damage to acquisition of desmoplastic phenotypes was investigated in primary human mammary fibroblasts (HMFs) co-cultured with vHMECs with telomere malfunction (TRF2-vHMEC) or in HMFs directly treated with DNA-damaging agents, respectively. Fibroblast reprogramming was assessed by monitoring increases in levels of selected protumorigenic molecules with quantitative polymerase chain reaction, enzyme-linked immunosorbent assay, and immunocytochemistry. Dependence of the induced phenotypes on activin A was evaluated by addition of exogenous activin A or activin A silencing. In vitro findings were validated in vivo, in preinvasive ductal carcinoma in situ (DCIS) lesions by using immunohistochemistry and telomere-specific fluorescent in situ hybridization. Results: HMFs either cocultured with TRF2-vHMEC or directly exposed to exogenous activin A or PGE 2 show increased expression of cytokines and growth factors, deposition of extracellular matrix (ECM) proteins, and a shift toward aerobic glycolysis. In turn, these "activated" fibroblasts secrete factors that promote epithelial cell motility. Interestingly, cell-intrinsic DNA damage in HMFs induces some, but not all, of the molecules induced as a consequence of cell-extrinsic DNA damage. The response to cell-extrinsic DNA damage characterized in vitro is recapitulated in vivo in DCIS lesions, which exhibit telomere loss, heightened DNA damage response, and increased activin A and cyclooxygenase-2 expression. These lesions are surrounded by a stroma characterized by increased expression of α smooth muscle actin and endothelial and immune cell infiltration. Conclusions: Thus, synergy between stromal and epithelial interactions, even at the initiating stages of carcinogenesis, appears necessary for the acquisition of malignancy and provides novel insights into where, when, and how the tumor stroma develops, allowing new therapeutic strategies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/bcr3368

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. Jackson SP Bartek J The DNA-damage response in human biology and disease Nature 2009 14 1071 1078 10.1038/nature08467 19847258 PMC2906700 · DOI · Paper page
  2. Olcina M Lecane PS Hammond EM Targeting hypoxic cells through the DNA damage response Clin Cancer Res 2010 14 5624 5629 10.1158/1078-0432.CCR-10-0286 20876254 PMC3000384 · DOI
  3. Reinhardt HC Schumacher B The p53 network: cellular and systemic DNA damage responses in aging and cancer Trends Genet 2012 14 128 136 10.1016/j.tig.2011.12.002 22265392 PMC4120491 · DOI · Paper page
  4. Crawford YG Gauthier ML Joubel A Mantei K Kozakiewicz K Afshari CA Tlsty TD Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program Cancer Cell 2004 14 263 273 10.1016/S1535-6108(04)00023-6 15050918 · DOI
  5. Fordyce C Fessenden T Pickering C Jung J Singla V Berman H Tlsty T DNA damage drives an activin a-dependent induction of cyclooxygenase-2 in premalignant cells and lesions Cancer Prev Res (Phila) 2010 14 190 201 10.1158/1940-6207.CAPR-09-0229 20028875 PMC2954106 · DOI · Paper page
  6. Gauthier ML Berman HK Miller C Kozakeiwicz K Chew K Moore D Rabban J Chen YY Kerlikowske K Tlsty TD Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors Cancer Cell 2007 14 479 491 10.1016/j.ccr.2007.10.017 17996651 PMC3605202 · DOI · Paper page
  7. Romanov SR Kozakiewicz BK Holst CR Stampfer MR Haupt LM Tlsty TD Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes Nature 2001 14 633 637 10.1038/35054579 11214324 · DOI · Paper page
  8. Davalos AR Coppe JP Campisi J Desprez PY Senescent cells as a source of inflammatory factors for tumor progression Cancer Metastasis Rev 2010 14 273 283 10.1007/s10555-010-9220-9 20390322 PMC2865636 · DOI · Paper page
  9. Kalluri R Zeisberg M Fibroblasts in cancer Nat Rev Cancer 2006 14 392 401 10.1038/nrc1877 16572188 · DOI · Paper page
  10. Olumi AF Grossfeld GD Hayward SW Carroll PR Tlsty TD Cunha GR Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium Cancer Res 1999 14 5002 5011 10519415 PMC3300837
  11. Orimo A Gupta PB Sgroi DC Arenzana-Seisdedos F Delaunay T Naeem R Carey VJ Richardson AL Weinberg RA Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion Cell 2005 14 335 348 10.1016/j.cell.2005.02.034 15882617 · DOI · Paper page
  12. Tlsty TD Coussens LM Tumor stroma and regulation of cancer development Annu Rev Pathol 2006 14 119 150 10.1146/annurev.pathol.1.110304.100224 18039110 · DOI
  13. Fiaschi T Chiarugi P Oxidative stress, tumor microenvironment, and metabolic reprogramming: a diabolic liaison Int J Cell Biol 2012 14 762 825 PMC3361160 22666258
  14. Rasanen K Vaheri A Activation of fibroblasts in cancer stroma Exp Cell Res 2010 14 2713 2722 10.1016/j.yexcr.2010.04.032 20451516 · DOI · Paper page
  15. Dvorak HF Weaver VM Tlsty TD Bergers G Tumor microenvironment and progression J Surg Oncol 2011 14 468 474 10.1002/jso.21709 21480238 PMC3277953 · DOI
  16. Holst CR Nuovo GJ Esteller M Chew K Baylin SB Herman JG Tlsty TD Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia Cancer Res 2003 14 1596 1601 12670910
  17. Hammond SL Ham RG Stampfer MR Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract Proc Natl Acad Sci USA 1984 14 5435 5439 10.1073/pnas.81.17.5435 6591199 PMC391719 · DOI
  18. Heaphy CM Subhawong AP Gross AL Konishi Y Kouprina N Argani P Visvanathan K Meeker AK Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes Mod Pathol 2011 14 194 200 10.1038/modpathol.2010.198 21057458 PMC4416483 · DOI
  19. Pavlides S Whitaker-Menezes D Castello-Cros R Flomenberg N Witkiewicz AK Frank PG Casimiro MC Wang C Fortina P Addya S Pestell RG Martinez-Outschoorn UE Sotgia F Lisanti MP The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma Cell Cycle 2009 14 3984 4001 10.4161/cc.8.23.10238 19923890 · DOI · Paper page
  20. Harris RE Cyclooxygenase-2 (cox-2) and the inflammogenesis of cancer Subcell Biochem 2007 14 93 126 10.1007/1-4020-5688-5_4 17612047 · DOI
  21. Hoellen F Kelling K Dittmer C Diedrich K Friedrich M Thill M Impact of cyclooxygenase-2 in breast cancer Anticancer Res 2011 14 4359 4367 22199301
  22. Ferreira MC Witz CA Hammes LS Kirma N Petraglia F Schenken RS Reis FM Activin A increases invasiveness of endometrial cells in an in vitro model of human peritoneum Mol Hum Reprod 2008 14 301 307 10.1093/molehr/gan016 18359784 · DOI
  23. Kang HY Huang HY Hsieh CY Li CF Shyr CR Tsai MY Chang C Chuang YC Huang KE Activin A enhances prostate cancer cell migration through activation of androgen receptor and is overexpressed in metastatic prostate cancer J Bone Miner Res 2009 14 1180 1193 10.1359/jbmr.090219 19257827 · DOI
  24. Singh B Berry JA Shoher A Ramakrishnan V Lucci A COX-2 overexpression increases motility and invasion of breast cancer cells Int J Oncol 2005 14 1393 1399 15809733
  25. Meeker AK De Marzo AM Recent advances in telomere biology: implications for human cancer Curr Opin Oncol 2004 14 32 38 10.1097/00001622-200401000-00007 14685090 · DOI · Paper page
  26. Meeker AK Argani P Telomere shortening occurs early during breast tumorigenesis: a cause of chromosome destabilization underlying malignant transformation? J Mammary Gland Biol Neoplasia 2004 14 285 296 15557801
  27. Fordyce CA Heaphy CM Bisoffi M Wyaco JL Joste NE Mangalik A Baumgartner KB Baumgartner RN Hunt WC Griffith JK Telomere content correlates with stage and prognosis in breast cancer Breast Cancer Res Treat 2006 14 193 202 16752076
  28. Hansel DE Meeker AK Hicks J De Marzo AM Lillemoe KD Schulick R Hruban RH Maitra A Argani P Telomere length variation in biliary tract metaplasia, dysplasia, and carcinoma Mod Pathol 2006 14 772 779 16557277
  29. Heaphy CM Baumgartner KB Bisoffi M Baumgartner RN Griffith JK Telomere DNA content predicts breast cancer-free survival interval Clin Cancer Res 2007 14 7037 7043 10.1158/1078-0432.CCR-07-0432 18056180 · DOI
  30. Rampazzo E Bonaldi L Trentin L Visco C Keppel S Giunco S Frezzato F Facco M Novella E Giaretta I Del Bianco P Semenzato G De Rossi A Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes Haematologica 2012 14 56 63 10.3324/haematol.2011.049874 21933855 PMC3248931 · DOI
  31. Chiavarina B Martinez-Outschoorn UE Whitaker-Menezes D Howell A Tanowitz HB Pestell RG Sotgia F Lisanti MP Metabolic reprogramming and two-compartment tumor metabolism: opposing role(s) of HIF1alpha and HIF2alpha in tumor-associated fibroblasts and human breast cancer cells Cell Cycle 2012 14 3280 3289 10.4161/cc.21643 22894905 PMC3466527 · DOI
  32. Guido C Whitaker-Menezes D Capparelli C Balliet R Lin Z Pestell RG Howell A Aquila S Andò S Martinez-Outschoorn U Sotgia F Lisanti MP Metabolic reprogramming of cancer-associated fibroblasts by TGF-beta drives tumor growth: connecting TGF-beta signaling with "Warburg-like" cancer metabolism and L-lactate production Cell Cycle 2012 14 3019 3035 10.4161/cc.21384 22874531 PMC3442913 · DOI
  33. Pavlides S Vera I Gandara R Sneddon S Pestell RG Mercier I Martinez-Outschoorn UE Whitaker-Menezes D Howell A Sotgia F Lisanti MP Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis Antioxid Redox Signal 2012 14 1264 1284 10.1089/ars.2011.4243 21883043 PMC3324816 · DOI
  34. Shim V Gauthier ML Sudilovsky D Mantei K Chew KL Moore DH Cha I Tlsty TD Esserman LJ Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium Cancer Res 2003 14 2347 2350 12750248
  35. Bartkova J Rezaei N Liontos M Karakaidos P Kletsas D Issaeva N Vassiliou LV Kolettas E Niforou K Zoumpourlis VC Takaoka M Nakagawa H Tort F Fugger K Johansson F Sehested M Andersen CL Dyrskjot L Ørntoft T Lukas J Kittas C Helleday T Halazonetis TD Bartek J Gorgoulis VG Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints Nature 2006 14 633 637 10.1038/nature05268 17136093 · DOI · Paper page
  36. Collado M Blasco MA Serrano M Cellular senescence in cancer and aging Cell 2007 14 223 233 10.1016/j.cell.2007.07.003 17662938 · DOI · Paper page
  37. Shay JW Roninson IB Hallmarks of senescence in carcinogenesis and cancer therapy Oncogene 2004 14 2919 2933 10.1038/sj.onc.1207518 15077154 · DOI · Paper page
  38. Zdanov S Bernard D Debacq-Chainiaux F Martien S Gosselin K Vercamer C Chelli F Toussaint O Abbadie C Normal or stress-induced fibroblast senescence involves COX-2 activity Exp Cell Res 2007 14 3046 3056 10.1016/j.yexcr.2007.04.033 17560572 · DOI
  39. Chen YG Wang Q Lin SL Chang CD Chuang J Ying SY Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis Exp Biol Med (Maywood) 2006 14 534 544 16636301
  40. Reis FM Luisi S Carneiro MM Cobellis L Federico M Camargos AF Petraglia F Activin, inhibin and the human breast Mol Cell Endocrinol 2004 14 77 82 10.1016/j.mce.2004.02.016 15451571 · DOI
  41. Krneta J Kroll J Alves F Prahst C Sananbenesi F Dullin C Kimmina S Phillips DJ Augustin HG Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors Cancer Res 2006 14 5686 5695 10.1158/0008-5472.CAN-05-3821 16740706 · DOI
  42. Reis FM Cobellis L Tameirao LC Anania G Luisi S Silva IS Gioffre W Di Blasio AM Petraglia F Serum and tissue expression of activin a in postmenopausal women with breast cancer J Clin Endocrinol Metab 2002 14 2277 2282 10.1210/jc.87.5.2277 11994376 · DOI
  43. Sjöblom T Jones S Wood LD Parsons DW Lin J Barber TD Mandelker D Leary RJ Ptak J Silliman N Szabo S Buckhaults P Farrell C Meeh P Markowitz SD Willis J Dawson D Willson JK Gazdar AF Hartigan J Wu L Liu C Parmigiani G Park BH Bachman KE Papadopoulos N Vogelstein B Kinzler KW Velculescu VE The consensus coding sequences of human breast and colorectal cancers Science 2006 14 268 274 10.1126/science.1133427 16959974 · DOI
  44. Mylonas I Jeschke U Shabani N Kuhn C Friese K Gerber B Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis Oncol Rep 2005 14 81 88 15583806
  45. Reinholz MM Iturria SJ Ingle JN Roche PC Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR Breast Cancer Res Treat 2002 14 255 269 10.1023/A:1016339120506 12206515 · DOI
  46. Kim H Watkinson J Varadan V Anastassiou D Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1 BMC Med Genomics 2010 14 51 10.1186/1755-8794-3-51 21047417 PMC2988703 · DOI
  47. Robinson GW Hennighausen L Inhibins and activins regulate mammary epithelial cell differentiation through mesenchymal-epithelial interactions Development 1997 14 2701 2708 9226441
  48. Sobral LM Bufalino A Lopes MA Graner E Salo T Coletta RD Myofibroblasts in the stroma of oral cancer promote tumorigenesis via secretion of activin A Oral Oncol 2011 14 840 846 10.1016/j.oraloncology.2011.06.011 21727023 · DOI
  49. Incorvaia L Badalamenti G Rini G Arcara C Fricano S Sferrazza C Di Trapani D Gebbia N Leto G MMP-2, MMP-9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone Anticancer Res 2007 14 1519 1525 17595770
  50. Leto G Incorvaia L Badalamenti G Tumminello FM Gebbia N Flandina C Crescimanno M Rini G Activin A circulating levels in patients with bone metastasis from breast or prostate cancer Clin Exp Metastasis 2006 14 117 122 10.1007/s10585-006-9010-5 16841234 · DOI
  51. Kojima Y Acar A Eaton EN Mellody KT Scheel C Ben-Porath I Onder TT Wang ZC Richardson AL Weinberg RA Orimo A Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts Proc Natl Acad Sci USA 2010 14 20009 20014 10.1073/pnas.1013805107 21041659 PMC2993333 · DOI
  52. Ronnov-Jessen L Petersen OW Koteliansky VE Bissell MJ The origin of the myofibroblasts in breast cancer: recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells J Clin Invest 1995 14 859 873 10.1172/JCI117736 7532191 PMC295570 · DOI
  53. Spaeth EL Dembinski JL Sasser AK Watson K Klopp A Hall B Andreeff M Marini F Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression PLoS One 2009 14 e4992 10.1371/journal.pone.0004992 19352430 PMC2661372 · DOI · Paper page
  54. Delli Carpini J Karam AK Montgomery L Vascular endothelial growth factor and its relationship to the prognosis and treatment of breast, ovarian, and cervical cancer Angiogenesis 2010 14 43 58 10.1007/s10456-010-9163-3 20229258 · DOI
  55. Singh B Vincent L Berry JA Multani AS Lucci A Cyclooxygenase-2 expression induces genomic instability in MCF10A breast epithelial cells J Surg Res 2007 14 220 226 10.1016/j.jss.2007.01.039 17418864 · DOI
  56. DeNardo DG Johansson M Coussens LM Immune cells as mediators of solid tumor metastasis Cancer Metastasis Rev 2008 14 11 18 10.1007/s10555-007-9100-0 18066650 · DOI

Cited by

Sorted by citations

Authors
Fordyce, C. A., Patten, K. T., Fessenden, T. B., DeFilippis, R., Hwang, E. S., Zhao, J., & Tlsty, T. D.
Affiliations
  • University of California, San Francisco (US)
  • University of Chicago (US)
  • Duke University (US)
Corresponding author
Tlsty, Thea D
Venue
Breast Cancer Research
Published
2012-12-07
Volume
14
Issue
6
Pages
R155-R155
ISSN
  • 1465-5411 (ISSN-L)
  • 1465-542X
OpenAlex
W2171102578
Cited by
50
References
7
Citations by year
2026: 1 · 2025: 1 · 2024: 6 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 7 · 2019: 2 · 2018: 1 · 2017: 6 · 2016: 2 · 2015: 4 · 2014: 7 · 2013: 6
FWCI
2.19
Type
journal article
Language
en
Open access
Locations
  • Breast Cancer Research (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • Johns Hopkins University
  • National Institutes of Health (PO1 CA107584)
  • School of Medicine, Stanford University
  • Kaiser Foundation Research Institute
  • University of California, San Francisco
  • National Cancer Institute (CA097214, R01CA097214, CA107584, CA143803, U54CA143803, P01CA107584)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
Keywords
activin A, tumor stroma, desmoplasia, fibroblast reprogramming, DNA damage, telomere dysfunction, TRF2, mammary fibroblasts, mammary epithelial cells, ductal carcinoma in situ, cyclooxygenase-2, extracellular matrix deposition, aerobic glycolysis, epithelial cell motility, stromal-epithelial interactions, tumor microenvironment, preinvasive breast cancer, alpha-smooth muscle actin
MeSH terms
Actins, Carcinoma, Intraductal, Noninfiltrating, Cell Movement, Cell Transformation, Neoplastic, Cells, Cultured, DNA Damage, DNA Repair, Epithelial Cells, Fibroblasts, Glycolysis, Humans, Stress, Physiological, Dinoprostone, Telomere, Coculture Techniques, Activins, Mammary Glands, Human, Cyclooxygenase 2, Telomere Homeostasis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review